Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-24-006572
Filing Date
2024-11-14
Accepted
2024-11-14 13:00:16
Documents
1

Document Format Files

Seq Description Document Type Size
1 ZEVRA THERAPEUTICS, INC. p24-3057sc13g.htm SC 13G 48705
  Complete submission text file 0000902664-24-006572.txt   50557
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
ZEVRA THERAPEUTICS, INC. (Subject) CIK: 0001434647 (see all company filings)

EIN.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88808 | Film No.: 241459655
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 4 EMBARCADERO CENTER SUITE 3450 SAN FRANCISCO CA 94111
Business Address 4 EMBARCADERO CENTER SUITE 3450 SAN FRANCISCO CA 94111 415-801-4550
Woodline Partners LP (Filed by) CIK: 0001784547 (see all company filings)

EIN.: 831749088 | State of Incorp.: DE
Type: SC 13G